The mean SD of reduced GSH level for the age groups 1530 years, 3145 years, and over 46 years were 7.13 2.23, 5.14 1.42, and 2.55 0.464 ng/mL, respectively, for Group A, whereas the mean SD of reduced GSH level for the age groups 1530 years, 3145 years, and over 46 years were 17.99 3.29, 15.88 3.31, and 13.6 2.31 ng/mL, respectively, for Group B
Its non-synthetic profile and the fact that it's backed by research reassures users who aim to reduce reliance on over-the-counter painkillers, making it a confident addition for those who are less inclined to experiment with complex supplements
counterion content
Second, as the main analysis, we used a per-protocol approach to estimate the increased risk of SIS in GLP-1RA vs SGLT-2i users